ZEAL- Guggenheim - kursmål 235
-
Zealand Pharma/Guggenheim: Indleder dækning med køb
06:36
Det amerikanske investeringshus Guggenheim Securities har indledt dækning af det danske biotekselskab Zealand Pharma.Guggenheim indleder sin dækning af selskabet med den positive anbefaling køb.
Finanshuset sætter samtidig et kursmål for aktien på 235 kr., hvilket giver et stigningspotentiale på 39,5 pct. fra torsdagens lukkekurs på 168,50 kr, hvor den faldt 0,2 pct.
Data fremgår af Bloomberg News.
/ritzau/FINANS
Mads Sejer Nielsen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind